Segui
Minh-Dao Duong-Thi
Minh-Dao Duong-Thi
Postdoctoral Research Associate
Email verificata su olemiss.edu
Titolo
Citata da
Citata da
Anno
Weak affinity chromatography as a new approach for fragment screening in drug discovery
MD Duong-Thi, E Meiby, M Bergström, T Fex, R Isaksson, S Ohlson
Analytical biochemistry 414 (1), 138-146, 2011
932011
Design and synthesis of ligand efficient dual inhibitors of janus kinase (JAK) and histone deacetylase (HDAC) based on ruxolitinib and vorinostat
L Yao, N Mustafa, EC Tan, A Poulsen, P Singh, MD Duong-Thi, JXT Lee, ...
Journal of medicinal chemistry 60 (20), 8336-8357, 2017
892017
Identification of the benzodiazepines as a new class of antileishmanial agent
RL Clark, KC Carter, AB Mullen, GD Coxon, G Owusu-Dapaah, ...
Bioorganic & medicinal chemistry letters 17 (3), 624-627, 2007
652007
High-throughput fragment screening by affinity LC-MS
MD Duong-Thi, M Bergström, T Fex, R Isaksson, S Ohlson
Journal of Biomolecular Screening 18 (2), 160-171, 2013
432013
Fragment screening for drug leads by weak affinity chromatography (WAC-MS)
S Ohlson, MD Duong-Thi
Methods 146, 26-38, 2018
252018
Comparison of weak affinity chromatography and surface plasmon resonance in determining affinity of small molecules
MD Duong-Thi, G Bergström, CF Mandenius, M Bergström, T Fex, ...
Analytical biochemistry 461, 57-59, 2014
232014
Lipodisks integrated with weak affinity chromatography enable fragment screening of integral membrane proteins
MD Duong-Thi, M Bergström, K Edwards, J Eriksson, S Ohlson, JTY Ying, ...
Analyst 141 (3), 981-988, 2016
172016
Weak affinity chromatography for evaluation of stereoisomers in early drug discovery
MD Duong-Thi, M Bergström, T Fex, S Svensson, S Ohlson, R Isaksson
Journal of Biomolecular Screening 18 (6), 748-755, 2013
122013
Analysis of protein target interactions of synthetic mixtures by affinity-LC/MS
P Singh, K Madhaiyan, MD Duong-Thi, BW Dymock, S Ohlson
SLAS DISCOVERY: Advancing Life Sciences R&D 22 (4), 440-446, 2017
102017
Toward high‐throughput drug screening on a chip‐based parallel affinity separation platform
S Ohlson, MD Duong‐Thi, M Bergström, T Fex, L Hansson, L Pedersen, ...
Journal of separation science 33 (17‐18), 2575-2581, 2010
92010
Emerging technologies for fragment screening
S Ohlson, MD Duong‐Thi
Fragment‐based Drug Discovery Lessons and Outlook, 173-196, 2016
82016
Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta induced protein (TGFBIp) offers a new avenue for treatment of TGFBI-corneal dystrophy
A Venkatraman, MD Duong-Thi, K Pervushin, S Ohlson, JS Mehta
Journal of Advanced Research 24, 529-543, 2020
62020
Weak Affinity Chromatography (WAC)
S Ohlson, MD Duong‐Thi
Applied Biophysics for Drug Discovery, 107-130, 2017
42017
Metabolism of two new benzodiazepine-type anti-leishmanial agents in rat hepatocytes and hepatic microsomes and their interaction with glutathione in macrophages
RLC M Dao Duong Thi, M Helen Grant, Alexander B Mullen, Justice N A Tettey ...
J Pharm Pharmacol. 61 (3), 399-406, 2009
42009
Engineering a tunable micropattern‐array assay to sort single extracellular vesicles and particles to detect RNA and protein in situ
J Zhang, XY Rima, X Wang, LTH Nguyen, K Huntoon, Y Ma, PL Palacio, ...
Journal of Extracellular Vesicles 12 (11), 12369, 2023
22023
Introducing weak affinity chromatography to drug discovery with focus on fragment screening
MD Duong-Thi
Linnaeus University Press, 2013
22013
Methods using weak interaction chromatography to separate and determine affinities of stereoisomers
S Ohlson, MD Duong-Thi, E Meiby, R Isaksson, T Fex
2012
In Vitro Metabolism Studies of Two New Benzodiazepine-type Antileishmanial Agents
MDD Thi
2006
WEAK AFFINITY CHROMATOGRAPHY (WAC) AS A NEW APPROACH FOR FRAGMENT–BASED DRUG DISCOVERY
MD Duong-Thi
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–19